Alexis Desieno Sells 7,487 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 7,487 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $3.08, for a total transaction of $23,059.96. Following the completion of the sale, the chief financial officer now directly owns 97,849 shares in the company, valued at $301,374.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Cardlytics Stock Up 7.5 %

Cardlytics stock opened at $3.29 on Friday. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The stock has a fifty day simple moving average of $4.35 and a two-hundred day simple moving average of $8.52. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. The firm has a market cap of $160.50 million, a price-to-earnings ratio of -0.74 and a beta of 1.67.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.12. The firm had revenue of $69.64 million during the quarter, compared to analysts’ expectations of $75.39 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The firm’s quarterly revenue was down 9.2% on a year-over-year basis. During the same period in the previous year, the company earned ($0.57) earnings per share. Equities analysts predict that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

Hedge funds have recently added to or reduced their stakes in the stock. Canton Hathaway LLC grew its holdings in shares of Cardlytics by 95.7% in the second quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock worth $37,000 after acquiring an additional 2,200 shares during the period. XTX Topco Ltd purchased a new position in Cardlytics in the second quarter worth about $107,000. Banco Santander S.A. bought a new stake in shares of Cardlytics during the 1st quarter valued at about $199,000. SG Americas Securities LLC bought a new stake in shares of Cardlytics during the 3rd quarter valued at about $45,000. Finally, Quest Partners LLC increased its position in shares of Cardlytics by 160.4% during the 2nd quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after purchasing an additional 11,061 shares during the last quarter. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CDLX has been the topic of several research reports. Needham & Company LLC lowered shares of Cardlytics from a “buy” rating to a “hold” rating in a research note on Thursday, August 8th. Northland Securities downgraded Cardlytics from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $7.00 to $5.00 in a research note on Friday, August 16th. Lake Street Capital lowered Cardlytics from a “buy” rating to a “hold” rating and reduced their price objective for the company from $18.00 to $5.00 in a research report on Thursday, August 8th. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Finally, Bank of America downgraded shares of Cardlytics from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $7.50.

Read Our Latest Report on CDLX

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.